Literature DB >> 3146925

Inherited lysosomal storage disease associated with deficiencies of beta-galactosidase and alpha-neuraminidase in sheep.

A J Ahern-Rindell1, D J Prieur, R D Murnane, S S Raghavan, P F Daniel, R H McCluer, S U Walkley, S M Parish.   

Abstract

Histopathologic, ultrastructural and Golgi impregnation studies disclosed lesions characteristic of a neuronal lysosomal storage disease in related sheep with onset of neurologic signs at 4-6 months. Biochemical and enzymatic evaluation disclosed storage of GM1 ganglioside, asialo-GM1, and neutral long chain oligosaccharides in brain, urinary excretion of neutral long chain oligosaccharides, and deficiencies of lysosomal beta-galactosidase and alpha-neuraminidase. Retrospective and limited prospective genetic studies suggested autosomal recessive inheritance. A gene-dosage effect on beta-galactosidase levels was documented in fibroblasts from putative heterozygous sheep. Fibroblasts from affected sheep did not have increased beta-galactosidase activity after incubation with the protease inhibitor, leupeptin. In some aspects this disease is similar to GM1 gangliosidosis, but is unique in that a genetic defect in lysosomal beta-galactosidase may cause the deficiency of lysosomal alpha-neuraminidase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3146925     DOI: 10.1002/ajmg.1320310108

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  Ovine GM-1 gangliosidosis.

Authors:  D J Prieur; A J Ahern-Rindell; R D Murnane
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

2.  The lesions of an ovine lysosomal storage disease. Initial characterization.

Authors:  R D Murnane; D J Prieur; A J Ahern-Rindell; S M Parish; L L Collier
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

3.  Lectin histochemistry of an ovine lysosomal storage disease with deficiencies of beta-galactosidase and alpha-neuraminidase.

Authors:  R D Murnane; A J Ahern-Rindell; D J Prieur
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

4.  Canine GM1-gangliosidosis. A clinical, morphologic, histochemical, and biochemical comparison of two different models.

Authors:  J Alroy; U Orgad; R DeGasperi; R Richard; C D Warren; K Knowles; J G Thalhammer; S S Raghavan
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

5.  A new form of ovine GM1-gangliosidosis.

Authors:  B J Skelly; M Jeffrey; R J Franklin; B G Winchester
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 6.  Neurobiology and cellular pathogenesis of glycolipid storage diseases.

Authors:  Steven U Walkley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237

7.  Axonopathy and Reduction of Membrane Resistance: Key Features in a New Murine Model of Human GM1-Gangliosidosis.

Authors:  Deborah Eikelberg; Annika Lehmbecker; Graham Brogden; Witchaya Tongtako; Kerstin Hahn; Andre Habierski; Julia B Hennermann; Hassan Y Naim; Felix Felmy; Wolfgang Baumgärtner; Ingo Gerhauser
Journal:  J Clin Med       Date:  2020-04-02       Impact factor: 4.241

8.  In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses.

Authors:  Moeko Kohyama; Akira Yabuki; Kenji Ochiai; Yuya Nakamoto; Kazuyuki Uchida; Daisuke Hasegawa; Kimimasa Takahashi; Hiroaki Kawaguchi; Masaya Tsuboi; Osamu Yamato
Journal:  BMC Vet Res       Date:  2016-03-31       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.